Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still watching for our dopamine agonist approval.
Haha. Now reply to yourself and agree with yourself.
This is the way
Doesn’t matter - .15. Shut your mouth and get out.
Haha. Is this an attempt to make something negative out of a +6.76% move up on almost 4 million volume, immediately after a +39.50% move up on Friday on over 5 million volume??
LOL.
Pretty weak and stupid but do what ya gotta do I guess, shortie. That cat has been outta the bag for awhile now.
That’s what I’m getting at. What if you are “first to file” but your application is garbage and gets a CRL a few months down the road for whatever reason. Surely the company who filed next and with a better application and gets approval actually obtains the exclusivity period.
Doesn’t the FDA first have to review all the applications that filed and see whether they get approved or not to ultimately determine who got first to file…?
“The narrative of the company has fundamentally changed.” 100%.
AFAIK, we won’t know about Oxy first to file until either Elite receives the approval letter where it is explicitly stated, or if it becomes known otherwise that a different company has gotten it.
But we both know you were never leaving at .15 to begin with, right? Still assigned here.
Much rather just have Elite be acquired, even if for a slightly lesser price, than roll the dice on a reverse split. These short seller maggots will do all they can to drop the price afterward.
Theoretically, does Elite even need to uplist at all before being acquired?
He did also say buybacks would be on the table after debt was paid off. I do hope your 6-12 months is accurate but wouldn’t surprise me to see it take a little longer than that.
Ya, it sucked there for years starting the reinvention of the company almost near ground zero but now that some money is coming in, they can keep the conveyor belt of formulation > trials > filing > approval > launch going much more consistently.
Likely a dopamine agonist approval next week.
Hopefully Vigabatrin launch soon?
Likely record breaking, or at least still extremely good, financial report in less than a month.
Approaching 2 months since Vyvanse successful trial results so ANDA filing likely in the near future.
Prasco/Burel deal starts in little over 2 months.
Likely antimetabolite approval in 4ish months, while the dopamine agonist likely will have launched in the interim.
Nice string of catalysts in the queue!
$ELTP$ baby
I agree. Don’t want to act like first-to-file is a done deal, just sets us up for disappointment if it doesn’t happen. I hope we are first, though.
It will be another great feather in Elite’s cap in either case.
Kinda silly to see NWBO where it is compared to ELTP where it is, ain’t it?
Almost exact same outstanding share count but vastly different financial picture. Stock prices should be reversed, IMO.
Nah u ain’t. LOL
Correct
Whew so glad I took this advice and sold all my shares…
Not.
I like it! Rat MMs might dick with you though and jump the price around.
Good luck.
Is that you on the bid for .099 at roughly 250k shares? Lol
AJ! AJ! Good to see you post again.
Nice thing is by late Feb, a mere 4ish months away, we should have:
-Another banger of quarterly revs
-Dopamine agonist approval (maybe next week) and probably the launch as well
-Burel partnership rolling
-Antimetabolite approval
-Vyvanse ANDA filing acceptance by FDA
*Add in any possible unknown unknowns*
The sudden desperation around here makes more sense by the day, tick tock
I wonder if we are in *the* OTC stock that brings in more revenues (and maybe profits) than any other?
Thanks, selling all my shares right now!!!
Low effort, low energy
Silly that we’re still at a dime with everything in the hopper.
What do you anticipate a reasonable acquisition price would be and when?
Should have some next week or so.
Ok but 15c Nasrat sell co?
Aye we should.
?
15 cent sell Nasrat?
Bleep bloop “Nasrat plz sell company 15 cent”
What is illegal about selling shares?
What are you talking about?
Used to be “they’ll go bankrupt, they’ll never get XYZ approved, ‘puny’ revenues” etc.
Now we’re projecting north of $40M revenues annually as it is, and arguing whether revenues off the upcoming new drugs will be in 8 or 9 figures of added revenues.
Are we there yet
Not sure why either. Will be interesting to see if they call Vyvanse by name when we see the next filing PR.
The FDA acceptance of that filing was today.
8k for what?
I mean when the FDA approves it months from now, not re: today’s news.
It will be explicitly stated in the approval letter the FDA sends Elite, if it applies.
Or if we notice any other pharma getting approval before us I suppose.